Cholesterol: its regulation and role in central nervous system disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review of CNS cholesterol metabolism and related disorders without primary data or systematic search methodology.
PubMed 23119149 · doi:10.1155/2012/292598
What was done
Narrative review summarizing metabolic pathways of cholesterol in the central nervous system, cell-specific and microdomain-specific interactions (such as with amyloid precursor protein), related neurological disorders, and the potential impact of LDL cholesterol-lowering drugs.
What was found
The abstract reports no empirical numbers or quantitative findings. It describes that brain cholesterol is derived primarily via de novo synthesis because the blood-brain barrier prevents circulating lipoprotein uptake, and notes that defects across biosynthesis, lipid transport, apolipoproteins, lipoprotein receptors, and signaling molecules underlie conditions such as Smith-Lemli-Opitz syndrome, Niemann-Pick type C disease, and Alzheimer's disease.
Why it matters
The review outlines the distinct compartmentalization of brain cholesterol metabolism and highlights how metabolic disruptions contribute to diverse structural and functional central nervous system disorders.
Limits
This is a narrative review presenting no primary human experimental data, clinical trials, or quantitative synthesis. The abstract does not report search methodology, sample sizes, or numerical effect estimates.
Cited by
- supports The human brain does not take up cholesterol from the bloodstream, but synthesizes its own cholesterol locally.